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Background: Depressive symptoms are highly prevalent among patients with multiple sclerosis (MS). Web-
based problem solving therapy (PST) is easily accessible and showed to be effective in depressed patients.
Objectives: The aims of this pilot study were to examine feasibility and outcome (reduction of depressive
symptoms) of an applied web-based PST intervention in MS patients.
Methods: Forty-four MS patients with mild to severe depressive symptoms followed a web-based PST interven-
tion. Feasibilitywasmeasured by compliance rate and satisfaction scales. The Beck Depression Inventory (BDI-II)
was used to measure depressive symptoms before and after the intervention.
Results: The compliance rate was 52%, and 85% of the patients rated the quality of the intervention as good or ex-
cellent. After the intervention, depressive symptoms had signiﬁcantly decreased (BDI-II change: mean=−3.9,
p=0.01, d=0.51 in intention-to-treat analysis; BDI-II change: mean=−9.0, pb0.001, d=1.50 in completers
analysis).
Conclusions: This study suggests that applied web-based PST is feasible and reduces depressive symptoms inMS
patients. Especially MS patients who experience disease-related or other barriers to participate in face-to-face
counselling could beneﬁt. However, ways to increase compliance should be considered. A randomized controlled
trial is recommended to more extensively investigate effectiveness of this intervention in treating depressive
symptoms in MS patients.© 2011 Elsevier B V. . Open access under the Elsevier OA license.1. Introduction
Depressive symptoms are highly prevalent in patients withmultiple
sclerosis (MS). Lifetime risk for depression in the MS population has
been estimated at around 50%, compared with 10–15% in the general
population [1,2]. Depression is related to poorer quality of life, disrupts
social support and family systems, and has been associatedwith fatigue,
a cutback in working hours and cognitive impairment in MS patients
[1]. The risk of suicide is 2.3 times elevated in the MS population [3],
with the most important risk factor for suicide being a depressive
episode [4]. Furthermore, depression can result in decreased adherence
to MS treatment, which may affect health status adversely [5]. It
remains unclear whether depressive symptoms in patients with MSal Center Academic Anxiety
rdam, The Netherlands.
eschoten).
lsevier OA license.are primarily reactive in nature as a response to the unpredictable and
uncertain course of the disease, or whether neurobiological factors
play a part [1,6].
More than half of the cases of depression in MS patients are under-
diagnosed [7,8]. Possible reasons could be that patients perceive their
emotional problems as an unsolvable component of the disease process,
therefore leaving themunmentioned in the consulting roomof the phy-
sician. In addition, mental problems are not the primary focus of physi-
cians and general practitioners [9]. Besides, if depressive symptoms are
recognized, adequate treatment often tends to be lacking [1,10].
A number of clinical trials on cognitive behavior therapy (CBT) have
shown that psychotherapy is an effective treatment for depression in
patients who suffer from MS [1,9,11,12]. This applies especially to
depression treatment that focuses on developing skills to cope with
the unpredictable and uncertain course of MS and its consequences
[9,13]. Problem solving therapy (PST), comprising a cognitive behavior-
al method, is based on the assumption that psychological symptoms of
depression are often caused by (practical) problems people face in their
260 invited for screening 
44 enrolled in study 
Declinations 
56 no reaction 
29 not interested 
15 no definite MS 
9 no Internet access 
1 passed away 150 completed screening 
Exclusions 
96 BDI < 16 
4 in psychotherapy 
2 physical problems 
4 refused to participate 
Fig. 1. Patients' ﬂow.
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to solve these problems in a structured way by teaching themmore ad-
equate problem-solving skills [14,15]. Several studies found PST to be
effective in the treatment of depression [16,17]. However, MS patients
can experience additional difﬁculties in attending psychotherapy treat-
ment due to disease-related factors such as fatigue, physical impair-
ments and transportation difﬁculties. These complicating factors seem
to have a major impact on receiving face-to-face treatment [12,18].
To avoid the aforementioned barriers that hamper ordinary psycho-
therapeutic treatment, other forms of treatment delivery can be intro-
duced such as brief sessions, therapy by telephone or more self-help
orientated alternatives. During the past years there has been a signiﬁ-
cant increase in the use of telecommunication to provide self-help
oriented psychotherapy for a wide range of psychiatric conditions.
Recent ﬁndings show that CBT provided by telephone or using the In-
ternet is an effective method of treatment for depression in general
[19–21]. In depressed MS patients, Mohr and colleagues found a signif-
icantly larger decrease of depressive symptoms in those receiving a
telephone-administered CBT compared to those receiving supportive
emotion-focused therapy [18] or no mental healthcare at all [22].
These forms of treatment may result in a reduction of treatment
time, commuting time, and treatment costs. Furthermore, they are
easily accessible and have the advantage of reaching a large number
of peoplewith functional impairments due to physical health problems.
Although web-based CBT has demonstrated to be effective in reducing
depressive symptoms, evidence is lacking whether this also applies to
depressive symptoms in MS patients.
Therefore, the aim of our pilot study is 1) to explore the feasibility of
using the Internet and PST as an alternative treatment opportunity for
reducing depressive symptoms in MS patients, and 2) to examine the
outcome of the intervention on symptoms of depression and on
additional measures of anxiety, quality of life, physical functioning
and problem-solving skills. If the web-based PST intervention would
turn out to be feasible with a positive outcome, a new treatment for
depressive symptoms in MS patients would become within reach.
2. Methods
2.1. Patients
The VU University Medical Center Amsterdam, the Netherlands,
provided a database containing all patients with deﬁnite MS who visit-
ed the Department of Neurology in 2008. FromMay to September 2009,
206MS patients were recruited from this database. Another 31 patients
withMS registered for this study through advertisement inMSnewslet-
ters, and 23 MS patients were directly referred by their neurologists at
the VU Medical Center.
All patients received a mailing with a username and password to ﬁll
out an online version of the Beck Depression Inventory (BDI-II) [23,24],
as an initial screening questionnaire on depressive symptoms. Patients
were included in the study if they [1] were 18 years or older, [2] scored
16 or higher on the BDI-II and [3] reported a diagnosis of MS conﬁrmed
by a neurologist (>3 months ago). Potential participantswere excluded
if they were currently receiving psychotherapy, did not have access to
the Internet, were physically unable to attend an online intervention
or reported suicidal ideation. A reminder phone-call was used to en-
hance the response rate.
2.2. Flow of patients
Two hundred sixty MS patients received an invitation to ﬁll out the
depression screening questionnaire, the response rate was 58%
(n=150). Fifty four of the respondingMS patients had a mild to severe
depression according to their score on the Beck Depression Inventory
(BDI-II ≥16); the other 96 patients (BDI-II b16), were excluded. Four
of the remaining 54 patients were excluded because they werereceiving psychotherapy, two were physically unable to attend an
online intervention, and four ﬁnally refused to participate. The remain-
ing 44 patients consented to participate in the pilot study. Fig. 1 de-
scribes the ﬂow of patients.
2.3. Procedures
We conducted a pilot study with one condition. The protocol of the
study was approved by the medical–ethical committee of the VU Uni-
versity Medical Center Amsterdam. Patients meeting inclusion criteria
received a letter concerning the research, content of the intervention
and an informed consent form. After giving informed consent, patients
were invited to ﬁll out a set of online questionnaires to obtain baseline
data. Finally, the depression and anxiety section of the World Health
Organization's Composite International Diagnostic Interview (WHO
CIDI, 1990) [25] was conducted by telephone. Patients then received a
password and username to access the online self-help intervention
from their personal computers via the Internet. Inclusion time to the
intervention was from April to November 2009. The PST intervention
(duration: 5 weeks), is further described in the section ‘Intervention’.
At completion of the web-based PST intervention, patients ﬁlled out
the online questionnaires of the post-intervention assessment. The
patients who did not complete the intervention received an invitation
for the post-intervention assessment 10 weeks after the baseline mea-
surement. Participation in the study did not interfere with the ongoing
MS treatment in any way.
3. Measures
3.1. Feasibility
Feasibility was measured by compliance rate and a self-designed 10
point Visual Analogue Scale (VAS) to evaluate the opinion of patients
about the website, support and the total intervention. We additionally
used the Client Satisfaction Questionnaire (CSQ-8) [26] to checkwheth-
er patients were satisﬁed with the care they received. The CSQ-8 has a
maximum achievable score of 32. For the VAS and the CSQ-8, higher
scores indicate more satisfaction.
3.2. Outcome
The BeckDepression Inventory [23,24] was used tomeasure depres-
sive symptoms. This self-report instrument is the most commonly used
measure of depression severity in patients with MS [1], and has shown
to be valid and reliable [27,28]. We used the Beck Depression Inventory
Second Edition (BDI-II) [23]which is themost recent version of the BDI.
It consists of 21-itemsmeasuring symptoms of depression, such as pes-
simism, sense of failure, guilt, self-dislike, suicidal ideas, insomnia and
weight loss. The total score is calculated as the sum score of all items
and ranges 0 to 63. Sum scores of 0–13 represent minimal depressive
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sion and 29–63 severe depression.
A number of additional outcomemeasureswere employed. The anx-
iety subscale of the Hospital Anxiety and Depression scale (HADS) [29]
was used to assess the presence of anxiety symptoms. This scale con-
sists of 7 items, with scores ranging from 0 to 21 with higher scores in-
dicating more anxiety. Since we already used the BDI-II to measure
depressive symptoms, the HADS was only used to measure anxiety
symptoms. In addition, we used the physical functioning subscale of
theMedical Outcome Study Short Form36 (SF-36) [30] and the EuroQol
quality of life measure [31], comprising a ﬁve-part questionnaire
(EQ-5D) and a visual analogue self-rating scale (EQ-VAS). Patients'
problem-solving skills were evaluated by the Social Problem Solving
Inventory Revised (SPSI-R) [32]. The SPSI-R consists of the following
subscales: negative and positive problem orientation (NPO, PPO), ratio-
nal problem solving (RPS), impulsivity/carelessness style (ICS) and
avoidance scale (AS). All questionnaires were administrated via the
Internet.
3.3. Other variables
A clinical diagnosis of Major Depression Disorder and/or Anxiety
Disorder according to DSM-IV-TR criteria was assessed by a telephone
interview using the WHO CIDI [25]. Finally, socio-demographic and
medicalMS data (i.e. year of diagnosis, onset of ﬁrst symptoms,medica-
tion usage, type of MS) were collected by online self-report.
3.4. Intervention
The online cognitive–behavioral self-help intervention examined in
this study is based onwhat is known as ‘problem-solving therapy’ (PST)
[14].We adjusted the original online PST-based intervention for depres-
sion as described by van Straten et al. [33] for MS patients with co-
morbid depression. Modiﬁcations concerned additional information
about MS and its psychosocial consequences, and adjustment of text
and examples. The intervention consisted of ﬁve modules containing
text, exercises and examples. Patients were asked to work on one
module a week and exercise for at least 2 h a week. Support during
the intervention consisted of communication via the website through
brief, weekly e-mails, andwas provided by supervised and trainedmas-
ter's clinical psychology students. The e-mail correspondence was
intended to facilitate the patient's effective use of the self-help method,
and was explicitly not intended to build up a patient–therapist
relationship.
3.5. Statistical analyses
We compared baseline characteristics for patients who completed
the intervention (completers) and patients who did not (non-com-
pleters): by performing chi-square comparisons for dichotomous
variables and independent t-test statistics for continuous variables.
Descriptive statistics of compliance rate and satisfaction were used
to explore the feasibility of web-based PST as an alternative treatment
opportunity for MS patients with co-morbid depressive symptoms.
Paired t-tests were performed to assess changes between pre-
intervention and post-intervention in order to determine the improve-
ment of patients during the intervention. We used both intention-to-
treat (ITT) analyses and completers analyses. In the ITT analyses, the
conservative Last Observation Carried Forward method (LOCF) was
used to impute data for those who did not complete post-intervention
assessments (n=4). To evaluate the magnitude of the improvement
of the intervention on outcome measures, effect sizes were calculated
for all patients and for completers only, using Cohen's formula [34]. Ef-
fect sizes were calculated by subtracting the post-intervention values
from the pre-intervention values, divided by the pooled standarddeviation. Effect sizes of 0.56 or higher can be assumed to be large,
while effect sizes of 0.33–0.55 are moderate, and effect sizes of 0–0.32
are small.
We used the method of Jacobson and Truax [35] to measure the
proportion of participants who improved and recovered. The reliable
change index (RCI) [35] was used to determine statistically signiﬁcant
change in the BDI-II from pre-intervention to post-intervention, at the
level of individual patients. The RCI was determined by subtracting a
patients' post-intervention score from the pre-intervention score and
dividing it by the standard error of difference between the two test
scores. Patients are seen as improved if the RCI is higher than 1.96,
since it would be unlikely that this change occurs by chance. A decrease
of 3.7 or more on the BDI-II implies in this case statistically reliable
change. Finally, recovery from depressive symptoms was deﬁned as
reliable change plus a score of 13 or lower on the BDI-II [36].
4. Results
4.1. Patients
Baseline characteristics of the 44 enrolled patients are displayed in
Table 1. Mean age was 45 years and the majority of patients were
female (77%) and married (68%). Education level was almost evenly
distributed in the study population with 43% lowly educated
(b15 years) and 57% highly educated (≥15 years). Time since MS diag-
nosis ranged from 2 to 40 years (median=5 years). Almost half of the
patients (48%) had the relapsing–remitting type of MS, 23% the
secondary-progressive type and 18% the primary-progressive type of
MS. For 11%, the type of MS was not reported.
Chi-square analyses and analyses of variance revealed nodifferences
in baseline characteristics between patients who completed the inter-
vention and patients who did not, except for the BDI-II. Baseline BDI-II
scores of completers were signiﬁcantly higher compared to non-
completers (mean=23 vs mean=17, p=0.01).
4.2. Feasibility
4.2.1. Compliance rate
The compliance rate for the web-based PST intervention was as fol-
lows: 91% completed the assignments of module 1, 70% additionally
completed module 2, 64% completed module 3, and 52% completed
the whole course (none of the patients dropped out between modules
4 and 5). We clustered the reported reasons of non-completers for
early termination of the intervention (n=21). For 24%, computer-
related problems were the main reason to drop out of the intervention
and 14% reported a lack of time and being too busy to ﬁnish the inter-
vention. Around 24% stopped the intervention because of psychosocial
and environmental problems as job loss, an ended relationship and per-
sonal or family matters. Other reasons (24%)wereMS related problems
as too much pain, illness, being too depressed, the intervention not
meeting someone's needs and wanting to ﬁnish the intervention in
their own time. For 14%, reasons for dropout were unknown.
4.2.2. Satisfaction
The CSQ-8 showed that 85% of the patients (n=40) rated the quality
of the web-based intervention as good or excellent. The majority of pa-
tients were satisﬁed with the amount of help they had received (77.5%)
and thought the web-based intervention had helped them to deal with
their emotional problems (75%). Around 62% reported that the web-
based PST had met their needs and 82.5% would recommend this kind
of therapy to others. Finally, 60% of the patientswould use the same inter-
vention if they needed help again. Themean CSQ-8 score in the total sam-
ple was 23.6 (sd 4.8, range=11–31). Patients who completed the
intervention expressed greater satisfaction with the intervention than
non-completers (mean=26.1 vs mean=20.1, pb0.001). Patients gave
their opinion about the website, support and total intervention on a
Table 1
Demographic characteristics.
Characteristics All patients
(n=44)
mean (sd) or %
Completers
(n=23)
mean (sd) or %
Non-completers
(n=21)
mean (sd) or %
p-value
Age, years 45 (12) 46 (11) 45 (13) 0.64
Sex, women 77 78 76 0.87
Education 0.74
Lower 43 48 43
Higher 57 52 57
Marital status 0.47
Married 68 74 62
Unmarried 32 26 38
Years since MS onset 0.63
Median (range) 5 (2–40) 5 (2–19) 3 (2–40)
Type of MS 0.24
Relapsing–remitting 48 52 44
Secondary progressive 23 19 26
Primary progressive 18 10 26
Unknown 11 19 4
MS medication
Disease modifying 60 (n=40) 61 59 (n=17) 0.38
Symptom relief 45 (n=40) 43 47 (n=17) 0.72
Psychotropic medication, yes 21 26 14 0.33
Diagnose CIDI 0.12
Depression 18 11 7
Anxiety 2 2 0
Depression and anxiety 10 6 4
No diagnosis 14 4 10
BDI-II pre-intervention 20 (7) 23 (7) 17 (7) 0.01
HADS pre-intervention 9 (3) 9 (3) 9 (3) 0.60
SF36pf pre-intervention 42 (32) 38 (30) 45 (34) 0.49
SPSI-R pre-intervention
PPO 11 (3) 10 (3) 11 (2.6) 0.16
NPO 18 (5) 20 (5) 16 (6) 0.06
ICS 17 (5) 17 (5) 16 (5) 0.31
RPS 37 (9) 36 (9.3) 38 (9) 0.50
AS 11 (4) 12 (4) 10 (4) 0.12
EuroQol pre-intervention
EQ-5D 0.56 (0.3) 0.58 (0.3) 0.54 (0.3) 0.66
EQ-VAS 62 (17) 61 (20) 63 (14) 0.75
MS =multiple sclerosis, CIDI = composite international diagnostic interview, BDI-II = Beck Depression Inventory, second edition, HADS = Hospital Anxiety and Depression Scale,
SF36pf = Short Form-36 physical functioning subscale, SPSI-R: PPO = positive problem orientation; NPO = negative problem orientation; RPS = rational problem solving; ICS =
impulsivity/carelessness style; AS = avoidance style, EQ-5D = EuroQol-5D, EQ-VAS = EuroQol-Visual Analogue Scale.
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ceived the highest rank, i.e. 7.7 (sd 1.2), the website scored 7.2 (sd 1.1)
and the total intervention scored 7.2 (sd 1.3). Differences in VAS score be-
tween completers and non-completers were signiﬁcant (mean=8.2 vs
mean=6.9, p=0.002, mean=7.5 vs mean=6.7, pb0.05, mean=7.7
vs mean=6.6, p=0.01).
4.3. Outcome
4.3.1. ITT and completers analyses
ITT analyses (n=44) revealed a signiﬁcant reduction in depressive
symptoms measured by the BDI-II. Fig. 2 shows that the mean score of20,1
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Fig. 2. Depressive symptoms before and after the web-based intervention. *p=0.01,
d=0.51, **pb0.001, d=1.5.depressive symptoms for all patients decreased from 20.1 to 16.2 with
a Cohen's d of 0.51 (p=0.01). Completers analyses (n=23) revealed
amore pronounced decrease (from22.8 to 13.8, pb0.001) in depressive
symptoms on the BDI-II with an effect size of Cohen's d=1.50. After
correction for baseline BDI-II scores, there was a signiﬁcant difference
in BDI-II change scores between completers (mean=−7.9) and non-
completers (mean=0.61) (pb0.001). Post-hoc analyses revealed that
patients with a CIDI diagnosis of Major Depression Disorder and/or
Anxiety Disorder (n=30) showed a signiﬁcant reduction of depressive
symptoms (mean BDI-II change=−5.5, p=0.002), with an effect size
of 0.74.
Table 2 presents mean pre- and post-intervention scores (sd),
t values and effect sizes for additional outcome measures. Completers
analyses but not ITT analyses revealed a signiﬁcant decrease in anxiety
measures (p=0.004) with a Cohen's d of 0.71. Regarding problem-
solving skills, the whole sample revealed a decrease in negative prob-
lem orientation (p=0.004; d=0.41), which was larger for patients
who completed the intervention (p=0.001, d=0.77). Additionally,
after the intervention, completers scored higher on positive problem
orientation (p=0.04) and rational problem solving (p=0.02). Finally,
the intervention did not seem to have any positive or negative conse-
quence for scores on physical functioning and quality of life scales,
and other subscales of the SPSI-R.
4.3.2. Signiﬁcance for individual patients
Based on the RCI, 47.7% of all patients (n=44) showed a signiﬁcant
improvement in depressive symptoms after the intervention. Seventy-
Table 2
Pre-intervention and post-intervention mean scores, standard deviations (sds), p and t values and effect sizes for additional outcome measures.
Measure ITT (n=44) Completers (n=23)
Pre-intervention
mean (sd)
Post-intervention
mean (sd)
t p d Pre-intervention
mean (sd)
Post-intervention
mean (sd)
t p d
HADS-A 9.2 (3.2) 8.3 (3.4) 1.74 0.09 0.27 9.4 (3.1) 7.2 (3.1) 3.7 0.001 0.71
SF36pf 41.5 (32) 41.4 (31.6) 0.79 0.94 −0.08 38.3 (30.0) 41.3 (29.2) −2.08 0.05 −0.10
EuroQol
EQ5D 0.56 (0.3) 0.59 (0.3) 0.86 0.40 −0.10 0.57 (0.3) 0.63 (0.2) −1.37 0.18 −0.24
VAS 62.0 (16.9) 63.6 (17.0) −0.89 0.38 −0.09 62.7 (13.9) 65.4 (16.5) −1.09 0.29 −0.06
SPSI-R
PPO 10.6 (2.7) 10.8 (2.6) −0.55 0.59 −0.08 10.0 (2.6) 11.4 (2.3) −2.19 0.04 −0.29
NPO 18.0 (5.4) 15.6 (6.3) 3.00 0.004 0.41 19.5 (4.8) 15.3 (6.0) 3.93 0.001 0.78
RPS 36.9 (9.1) 37.1 (11.5) −0.18 0.86 −0.02 36.0 (9.3) 39.7 (11.3) −2.60 0.02 −0.36
ICS 16.5 (4.9) 16.7 (5.4) −0.38 0.71 −0.04 17.2 (4.7) 16.9 (5.3) 0.33 0.75 0.06
AS 11.3 (3.9) 10.6 (5.5) 1.01 0.32 0.15 12.2 (4.0) 10.3 (6.0) 1.81 0.08 0.38
HADS = Hospital Anxiety and Depression Scale, SF36pf = Short Form-36 physical functioning subscale, SPSI-R: PPO = positive problem orientation; NPO = negative problem ori-
entation; RPS = rational problem solving; ICS = impulsivity/carelessness style; AS = avoidance style, EQ-5D = EuroQol-5D, EQ-VAS = EuroQol-Visual Analogue Scale.
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Fig. 3. Compliance rate of the web-based intervention compared with similar
interventions.
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(n=21) met the criteria for reliable change on the BDI-II
(χ2=18.008, pb0.001). Although a large part of patients still scored
within the depression range (BDI >13) at post-treatment, about one-
third of patients (29.5%) showed a reduction in depressive symptoms.
Recovery rate differed between completers (52.2%) and non completers
(4.8%) (χ2=11.854, p=0.001).
5. Discussion
This pilot study provides evidence that an adjusted version of
web-based PST is a feasible treatment for depressive symptoms in
patients with MS. More than half of the patients (52%) completed the
intervention and the majority (85%) reported to be satisﬁed with this
web-based intervention. Furthermore, our preliminary ﬁndings indi-
cate that the intervention can reduce depressive symptoms in MS
patients, especially in those who report more depressive symptoms at
baseline and complete the intervention. Apparently, this subgroup of
patients could beneﬁt most from this kind of treatment.
Our ﬁndings are in line with previous research that indicates that
PST improves depressive symptoms. A recent meta-analysis reported
mean pre-PST scores of 24.0 (sd=7.3) and post-PST scores of 11.2
(sd=11.2) on the BDI and BDI-II for depressed participants over eight
studies [37]. This is comparable to our observations in completers,
although it should be noticed that this meta-analysis was based on
studies that were carried out in other (not MS) populations using
another form of PST (not web-based). Apart from a decrease in depres-
sive symptoms, we also found the web-based intervention to improve
problem solving skills (negative and positive problem orientation and
rational problem solving) and reduce anxiety. However, the interven-
tion did not improve the speciﬁc problem solving styles of impulsivi-
ty/carelessness and avoidance, quality of life and physical functioning.
These results are encouraging since depression in MS patients often
goes undiagnosed [7,8], and if diagnosed, adequate treatment tends to
be lacking [1,10]. The fact that 36% of the responding patients
(n=150; before inclusion) in our study had mild to severe depressive
symptoms, and only four patients were receiving psychotherapy,
underscores these ﬁndings. With a web-based intervention we might
reach the group of un-served MS patients who are in need for suitable,
easily-accessible treatment for their depressive complaints. In our study
58% of the approached patients agreed to participate. While this is only
part of the target population, this number seems relatively high in com-
parison to a similar study in diabetes patients [38]. However, of the
approached patients who agreed to participate only half completed
the intervention.
Although web-based treatment has the advantage of reaching a large
number of people, it raises the risk of dropout since this kind of treatment
is fully the participant's own responsibility. In web-based self-helptreatment, it is much easier to postpone or end treatment when an effect
is noticed or when the symptoms become less urgent [39]. Recently, a
meta-analysis [40] suggests that people with less severe psychological
difﬁculties were more likely to drop out of web-based treatment which
is consistent with our ﬁnding that patients with less depressive symp-
toms at baseline were more prone to drop out of the intervention than
thosewith a higher baseline level of depressive symptoms.We compared
the compliance rate in this study with other studies examining a similar
web-based PST intervention (Fig. 3). The compliance rate of our study
(52%) was comparable to the compliance rates found in those studies
(55% [33] and 38% [15]). In addition, a recent meta-analysis found no dif-
ferences in dropout rates between face-to-face psychotherapy and guided
web-based self-help [21]. However, high dropout percentages fromweb-
based interventions have been identiﬁed as amajor challenge in e-health
interventions [41]. Additional research would be needed to understand
and prevent dropout in (future) web-based treatment [40]. As reasons
for early termination of the intervention, our patients reported computer
related problems, a lack of time or being too busy. This is in line with sev-
eral qualitative investigations of patient's reasons for dropping out of
web-based treatment [40]. Still, little is known about the speciﬁc factors
that could increase compliance rate [42].
Attempts to reduce dropouts contain for example modiﬁcation of
the intervention and sending postcard reminders or adding phone
calls [43]. Recently,Mohr and colleagues [42] executed a single-arm fea-
sibility trial to investigate the feasibility of a multimodal e-mental
health treatment for depressed patients and suggested that joint effects
of internet and telephone administered treatment for depression are
promising. In order to further increase the compliance rate, telephone
support could be considered in addition to, or instead of, email support
[15,44]. More support or time to practice with the website before the
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start up problems.
Although the outcome of the web-based intervention seems to be
promising, further research should include a control condition to con-
ﬁrm that the observed improvement does not represent the natural
course of depressive symptoms in patients with MS. However, several
studies have shown that depression in MS patients appears to be sta-
ble over time and does not diminish automatically without treatment
[45,46]. A randomized controlled trial with a longer follow-up and a
larger sample size is necessary to determine whether the web-
based PST intervention is indeed more effective than MS care as
usual and to assess its consequences in the long term. In our study,
MS diagnoses were obtained by self report on medical data and not
checked afterwards with the neurologist. As a result, MS diagnosis
was unknown for 11% of the patients. A written conﬁrmation of the
diagnosis from the patient's neurologist would enhance reliability.
Finally, cognitive behavior therapy for depressive symptoms has
shown to also reduce fatigue symptoms in MS patients [47]. In line
with this, web-based PST for depression could improve both depres-
sive and fatigue complaints in MS patients. It would therefore be
interesting to additionally examine fatigue measures as outcome.
In conclusion, the results of this pilot study are encouraging and sup-
port the initiation of a randomized controlled trial to more elaborately
investigate the effectiveness of a web-based PST intervention for
depressed MS patients. This intervention could especially beneﬁt
those who experience disease-related or other barriers to participation
in face-to-face counselling. With an easily accessible, cost-effective
web-based self-help intervention we can reach and treat many MS
patients with depressive symptoms and improve the quality of care.
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